Microsatellite abnormalities in plasma of patients with breast carcinoma: concordance with the primary tumour

被引:24
作者
Mayall, F
Fairweather, S
Wilkins, R
Chang, B
Nicholls, R
机构
[1] Waikato Hosp, Dept Pathol, Hamilton, New Zealand
[2] Univ Waikato, Dept Biol, Hamilton, New Zealand
关键词
tumour markers; breast carcinoma; polymerase chain reaction; microsatellite;
D O I
10.1136/jcp.52.5.363
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To detect microsatellite abnormalities in the primary tumours and plasma of patients with breast carcinoma. Methods-Plasma was obtained from 17 breast carcinoma patients before surgery. Corresponding tumour and benign lymph node (control) samples for each of the carcinoma patients were obtained from paraffin blocks. DNA was extracted from the plasma samples and the paraffin embedded tissue using previously described methods. Results-The 17 primary tumours showed two examples of loss of heterozygosity and three examples of microsatellite instability; the 17 plasma samples showed three and one, respectively. Many of the longer microsatellites lover 200 base pairs) were difficult to amplify from plasma. The investigations suggested that this was because of the highly fragmented nature of plasma DNA. Only one example of loss of heterozygosity and one example of microsatellite instability showed a concordant pattern in both primary tumour and plasma. These were both in the same patient. Conclusions-DNA mutations concordant with those in the primary carcinomas can occasionally be detected in the plasma of patients with breast carcinoma. However, the frequency would have to be markedly improved before this could be of any diagnostic value.
引用
收藏
页码:363 / 366
页数:4
相关论文
共 17 条
[1]   K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer [J].
Anker, P ;
Lefort, F ;
Vasioukhin, V ;
Lyautey, J ;
Lederrey, C ;
Chen, XQ ;
Stroun, M ;
Mulcahy, HE ;
Farthing, MJG .
GASTROENTEROLOGY, 1997, 112 (04) :1114-1120
[2]  
Chen XQ, 1996, NAT MED, V2, P1033
[3]   Microsatellite instability and loss of heterozygosity in mammary carcinoma and its probable precursors [J].
Dillon, EK ;
deBoer, WB ;
Papadimitriou, JM ;
Turbett, GR .
BRITISH JOURNAL OF CANCER, 1997, 76 (02) :156-162
[4]   PLASMA DNA AS A MARKER OF CANCEROUS CELL-DEATH - INVESTIGATIONS IN PATIENTS SUFFERING FROM LUNG-CANCER AND IN NUDE-MICE BEARING HUMAN TUMORS [J].
FOURNIE, GJ ;
COURTIN, JP ;
LAVAL, F ;
CHALE, JJ ;
POURRAT, JP ;
PUJAZON, MC ;
LAUQUE, D ;
CARLES, P .
CANCER LETTERS, 1995, 91 (02) :221-227
[5]   An efficient method for the extraction of DNA from vertebrate tissues [J].
Gemmell, NJ ;
Akiyama, S .
TRENDS IN GENETICS, 1996, 12 (09) :338-339
[6]  
LEON SA, 1977, CANCER RES, V37, P646
[7]   MICROSATELLITE ALTERATIONS AS CLONAL MARKERS FOR THE DETECTION OF HUMAN CANCER [J].
MAO, L ;
LEE, DJ ;
TOCKMAN, MS ;
EROZAN, YS ;
ASKIN, F ;
SIDRANSKY, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) :9871-9875
[8]   Mutations of p53 gene can be detected in the plasma of patients with large bowel carcinoma [J].
Mayall, F ;
Jacobson, G ;
Wilkins, R ;
Chang, B .
JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (08) :611-613
[9]   Cancer and mutant DNA in blood plasma [J].
Mulcahy, HE ;
Croke, DT ;
Farthing, MJG .
LANCET, 1996, 348 (9028) :628-628
[10]   Microsatellite alterations in serum DNA of head and neck cancer patients [J].
Nawroz, H ;
Koch, W ;
Anker, P ;
Stroun, M ;
Sidransky, D .
NATURE MEDICINE, 1996, 2 (09) :1035-1037